This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the drug Dupixent 300 mg/2 ml pen in the amount of $6,439.58 with a completion date of February 27, 2024.
Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations have been used for these contracts.
Generated 6/2/24, 12:25 AM